Ran Fei
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- interferon and immune responses
Papers in
- Hepatology 18
- Hepatitis C virus research 11
- Liver physiology and pathology 6
- Epidemiology 16
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 6
- Co-authors
- Lai Wei (30 shared papers)Hongsong Chen (34 shared papers)Xingwang Xie (15 shared papers)Cong Xu (26 shared papers)Dingkun Zhang (7 shared papers)Henghui Zhang (11 shared papers)Li Han (6 shared papers)Chuanhong Luo (3 shared papers)
- Journals
- Journal of Experimental & Clinical Cancer Research (3 papers)Journal of Gastroenterology and Hepatology (3 papers)Liver Transplantation (2 papers)Gels (1 paper)Clinical and Experimental Hypertension (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Ran Fei
82 papers receiving 1.4k citations
Ran Fei's Hit Papers
Peers
Comparison fields: 5 of 105
- Hepatology 235
- Immunology 418
- Pharmacology 84
- Biochemistry 54
- Oncology 219
Countries citing papers authored by Ran Fei
This map shows the geographic impact of Ran Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Fei more than expected).
Fields of papers citing papers by Ran Fei
This network shows the impact of papers produced by Ran Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Fei. The network helps show where Ran Fei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Fei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily Hit paper breakdown → | 2020 | 226 |
| 2 | 2015 | 221 | |
| 3 | 2019 | 95 | |
| 4 | 2004 | 57 | |
| 5 | 2021 | 46 | |
| 6 | 2009 | 38 | |
| 7 | 2006 | 37 | |
| 8 | 2007 | 36 | |
| 9 | 2014 | 35 | |
| 10 | 2013 | 34 | |
| 11 | 2021 | 26 | |
| 12 | 2016 | 25 | |
| 13 | 2009 | 24 | |
| 14 | 2020 | 23 | |
| 15 | Application of plasma circulating cell-free DNA detection to the molecular diagnosis of hepatocellular carcinoma. | 2019 | 23 |
| 16 | 2008 | 22 | |
| 17 | 2020 | 21 | |
| 18 | 2017 | 21 | |
| 19 | 2019 | 20 | |
| 20 | 2007 | 20 |
About Ran Fei
Ran Fei is a scholar working on Hepatology, Epidemiology, Molecular Biology, Immunology and Oncology, having authored 84 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (9 papers), Liver physiology and pathology (6 papers), Immunotherapy and Immune Responses (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Ubiquitin and proteasome pathways (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Organ Transplantation Techniques and Outcomes (3 papers). The work is most often cited by research in Hepatology (235 citations), Immunology (418 citations), Pharmacology (84 citations), Biochemistry (54 citations) and Oncology (219 citations). Ran Fei has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Lai Wei, Hongsong Chen, Xingwang Xie, Cong Xu, Dingkun Zhang, Henghui Zhang, Li Han, Chuanhong Luo, Feng Liu and Huiying Rao. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Journal of Gastroenterology and Hepatology, Liver Transplantation, Gels and Clinical and Experimental Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.